Publications by authors named "S Daenen"

Claim this Profile
Q
Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study.
K M Holtzer-Goor, M R Schaafsma, P Joosten, E F M Posthuma, S Wittebol, S M G J Daenen

Qual Life Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review.
Petros Pechlivanoglou, Hoa H Le, Simon Daenen, John A Snowden, Maarten J Postma

J Antimicrob Chemother· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study.
Arnon P Kater, Marjolein Spiering, Roberto D Liu, G Doreen Te Raa, E Slinger, Simon Daenen

Leuk Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world costs of chronic lymphocytic leukaemia in the Netherlands.
K M Holtzer-Goor, C A M Bouwmans-Frijters, M R Schaafsma, O de Weerdt, P Joosten, S M G J Daenen

Leuk Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: a randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON).
Noortje Thielen, Bronno van der Holt, Jan J Cornelissen, Gregor E G Verhoef, Titia Gussinklo, Simon M G Daenen

Eur J Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis